Skip to main content
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.88
-0.24 (-0.39%)
At close: Mar 9, 2026, 4:00 PM EDT
61.00
+0.12 (0.20%)
After-hours: Mar 9, 2026, 7:51 PM EDT

BioMarin Pharmaceutical Revenue

In the year 2025, BioMarin Pharmaceutical had annual revenue of $3.22B with 12.87% growth. BioMarin Pharmaceutical had revenue of $874.57M in the quarter ending December 31, 2025, with 17.03% growth.

Revenue (ttm)
$3.22B
Revenue Growth
+12.87%
P/S Ratio
3.63
Revenue / Employee
$1,000,079
Employees
3,221
Market Cap
11.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.22B367.34M12.87%
Dec 31, 20242.85B434.69M17.97%
Dec 31, 20232.42B323.19M15.42%
Dec 31, 20222.10B249.76M13.53%
Dec 31, 20211.85B-14.18M-0.76%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
Exelixis 2.32B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
BridgeBio Pharma 502.08M
ImmunityBio 113.29M
Praxis Precision Medicines 7.46M
Revenue Rankings

BMRN News

More News